This study sheds new light on rescuing TREM2 signaling in microglial cells through blocking LILRB2 suppression of TREM2, and reducing oAβ in AD patients by improving microglia phagocytosis functions. The gene discussed is LILRB2; the disease is Alzheimer disease.